ERBB2 and breast cancer: Trastuzumab (TZ)-grafted dendrimers were synthesized to achieve effective delivery of DTX to human epidermal growth factor receptor 2 (HER2)–positive breast cancer cells and which were more selective and had higher antiproliferation activity than HER2-negative cells.